LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Search

VIRIDIAN THERAPEUTICS INC

Closed

Sector Healthcare

22.24 3.01

Overview

Share price change

24h

Current

Min

21.96

Max

22.29

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+75.67 upside

Dividends

By Dow Jones

Next Earnings

8 Nov 2024

News Sentiment

By Acuity

26%

74%

68 / 390 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

VIRIDIAN THERAPEUTICS INC Chart

Past performance is not a reliable indicator of future results.

Related News

10 Sept 2024, 20:38 UTC

Acquisitions, Mergers, Takeovers

How This Amgen Rival Is Taking On The Company's $28 Billion Acquisition -- IBD

10 Sept 2024, 14:42 UTC

Acquisitions, Mergers, Takeovers

How This Amgen Rival Is Taking On The Company's $28 Billion Acquisition -- IBD

Peer Comparison

Price change

VIRIDIAN THERAPEUTICS INC Forecast

Price Target

By TipRanks

75.67% upside

12 Months Forecast

Average 39.14 USD  75.67%

High 61 USD

Low 22 USD

Based on 15 Wall Street analysts offering 12 month price targets forVIRIDIAN THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

13

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

21.53 / 23.25Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

68 / 390 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

$